Neometals (NMT) H2 2026 earnings summary

Executive summary

• FY2026 repositioning prioritized nearer-term cashflow, capital-light project pathways and reduced corporate costs; overheads fell ~16% and headcount 10% YoY.

• Portfolio focus spans Ironclad gold and Barrambie copper, Utah potassium-lithium brines, ELi commercialisation and externally financed vanadium recovery.

Financial highlights

• Total loss was $7.654m in FY2026, versus $31.016m in FY2025; continuing-operations loss was $14.030m, partly offset by $6.377m profit from discontinued operations.

• Cash and cash equivalents were $3.354m at 30 June 2026, down from $4.131m; net cash used in operating activities was $8.045m.

• Net cash outflows from operating and investing activities were $4.459m; total assets were $22.056m and net assets $15.755m at year-end.

• FY2026 EPS was a loss of 1.78 cents from continuing operations and 0.97 cents including discontinued operations, versus losses of 2.39 cents and 4.22 cents, respectively, in FY2025.

Outlook and guidance

• FY2027 priorities include Ironclad drilling, resource updates, approvals, tolling arrangements and potential FID with BML Ventures in H1 CY2027; mining remains conditional on key agreements and approvals.

• Utah evaluation will proceed in stages, with significant spending deferred until cashflow improves and joint-venture risks are mitigated; ~US$2m of qualifying spend over three years is required to retain 51%.

• ELi is targeting integrated, continuous validation using De Nora equipment and continued Rio Tinto engagement; external equity funding and beneficiation work remain priorities for vanadium recovery.

• If Ironclad reaches FID as planned, forecasts still indicate at least A$5m of additional funding will be needed progressively from December 2026 through September 2027.